Agenda

Welcome and Introduction

David-Alexandre C. Gros, M.D.
Chief Executive Officer | Eledon Pharmaceuticals

Overview of Tegoprubart

Steven Perrin, PhD
President and Chief Scientific Officer | Eledon Pharmaceuticals

IgA Nephropathy (IgAN)

Jonathan Barratt, M ChB, PhD, FRCP
Professor of Renal Medicine | University of Leicester

Amyotrophic Lateral Sclerosis (ALS)

Stanley H. Appel, MD
Co-Director of Houston Methodist Neurological Institute and Chair of the Stanley H. Appel Department of Neurology at Houston Methodist Hospital | Houston Methodist Neurological Institute, Houston Methodist Hospital

Kidney Transplantation

Flavio Vincenti, MD
Professor of Clinical Medicine | University of California San Francisco

Islet Cell Transplantation

Piotr Witkowski, MD, PhD
Associate Professor of Surgery at the Transplantation Institute and Director of the Pancreatic Islet Transplant Program | University of Chicago 

Tegoprubart Clinical Programs

Jeff Bornstein, MD
Chief Medical Officer | Eledon Pharmaceuticals

Q & A Session

Management + KOLs

Closing Remarks

David-Alexandre C. Gros, MD
Chief Executive Officer | Eledon Pharmaceuticals